Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer

Journal: Cancer Cell

Published: 2017-12-28

DOI: 10.1016/j.ccell.2017.11.018

Affiliations: 22

Authors: 34

Go to article
Institutions FC
Duke-NUS Cancer and Stem Cell Biology Program (CSCB), Singapore 0.26
Department of Gastroenterology and Hepatology, SGH, Singapore 0.09
Tan Tock Seng Hospital, Singapore 0.09
NUS Department of Medicine, Singapore 0.07
Department of Gastroenterology, Changi General Hospital, Singapore 0.06
Department of Anatomical Pathology, SGH, Singapore 0.06
NUHS University Medicine Cluster (UMC), Singapore 0.05
Institute of Medical Biology (IMB), A*STAR, Singapore 0.04
NUS Department of Pathology, Singapore 0.04
Department of General Surgery, Changi General Hospital, Singapore 0.03
Raffles Hospital, Raffles Medical Group, Singapore 0.03
Mount Elizabeth Medical Centre (MEMC), Singapore 0.03
Department of General Surgery, TTSH, Singapore 0.03
NUS Department of Surgery, Singapore 0.03
NUS Cancer Science Institute of Singapore (CSI), Singapore 0.02
MRC Centre for Regenerative Medicine (CRM), The University of Edinburgh, United Kingdom (UK) 0.01
Genome Institute of Singapore (GIS), A*STAR, Singapore 0.01
Singapore Gastrointestinal Cancer Consortium (SGiCC), Singapore 0.01
NUS Graduate School for Integrative Sciences and Engineering (NGS), Singapore 0.01
SingHealth Duke-NUS Institute of Precision Medicine (PRISM), Singapore 0
Division of Cellular and Molecular Research (CMR), NCCS, Singapore 0